Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Intranasal Ketamine Spray and Intravenous Morphine for Acute Headache Relief
IRCT20200602047633N2Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine and morphine in Headache (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Headache intensity reduction. Started Sep 2021; status: completed.
02
Drugs
ketaminemorphine
03
Conditions
Headache
Beyond the preview
Go deeper on IRCT20200602047633N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200602047633N2.